News | October 20, 2010

FDA Approves Safeguard for Prostate Cancer Radiotherapy

October 20, 2010 – The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for a system designed to automate the response to organ motion during prostate cancer radiotherapy. The Calypso System, by Calypso Medical Technologies, could help decrease the side effects associated with prostate radiotherapy, such as bowel and bladder incontinence and sexual dysfunction.

The system, and its GPS for the Body technology, utilizes miniature implanted Beacon transponders to provide precise, continuous information on the location of the tumor during external beam radiation therapy. The real-time position information provided by the Calypso System allows physicians to deliver maximum radiation directly to the tumor while sparing the surrounding healthy tissues and organs from exposure.

The new gating technology allows therapists to set motion thresholds which automatically signal radiation delivery to be stopped each time the targeted tissue moves outside the preset threshold. Previously, the therapist had to manually intervene and halt radiation delivery when healthy tissue was in danger of receiving unintended radiation. Dynamic Edge Gating Technology automates this function with an immediate signal to the linear accelerator so the radiation beam can be disabled or re-enabled in response to organ motion.

Side effects occur when the tumor moves outside of the radiation field in response to normal physiologic processes such as digestion, coughing and breathing, as well as small movements by the patient. As a result, healthy tissue receives the intended radiation, and at the same time, the tumor fails to receive the fully prescribed radiation dose.

"Calypso's Dynamic Edge Gating Technology is the next step in addressing organ motion for our patients," said Parag Parikh, M.D., assistant professor of radiation oncology at Washington University in St. Louis. "By automatically turning off the radiation beam if the target moves out of the planned location, this allows new ways to minimize the irradiation of healthy tissue, leading to better outcomes and quality of life for our patients."

In May 2010, Urology published a study that demonstrated that patients whose radiation therapy delivery was guided by the Calypso System experienced a significant decrease in the side effects associated with prostate radiation treatment.

For more information: www.calypsomedical.com

Related Content

RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Mirada Medical Showcases DLCExpert AI-Based Radiotherapy Contouring Software at ASTRO 2018
News | Treatment Planning | October 31, 2018
Medical imaging software company Mirada Medical showcased its DLCExpert at the recent American Society for Radiation...
Elekta Introduces Strategy for Precision Radiation Medicine at ASTRO 2018

Elekta SmartClinic is one of the key features in the Mosaiq Plaza suite of data-focused integrative oncology software

News | Radiation Therapy | October 30, 2018
At the American Society for Radiation Oncology (ASTRO) Annual Meeting, Oct. 21-24 in San Antonio, Elekta introduced the...
RaySearch Demonstrates New Machine Learning Applications at ASTRO
News | Radiation Therapy | October 29, 2018
RaySearch exhibited its latest advances in oncology software at the 2018 American Society for Radiation Oncology (ASTRO...
Sun Nuclear Surpasses 100 Units Shipped Milestone With SRS MapCheck
News | Quality Assurance (QA) | October 26, 2018
Sun Nuclear Corp. announced the 100th shipment of its new SRS MapCheck for stereotactic radiosurgery (SRS). The...
Siris Medical Releases PlanMD Decision Support Software
Technology | Treatment Planning | October 24, 2018
Siris Medical Inc. announced the release of its new artificial intelligence (AI) treatment decision-support system for...
Fujifilm Unveils FCT Embrace CT System for Oncology
Technology | Computed Tomography (CT) | October 23, 2018
Fujifilm Medical Systems U.S.A. Inc. recently introduced the FCT Embrace computed tomography (CT) system. Powered by...